Clinical Trial Update: Temozolomide in Treating Patients With Recurrent High-Grade Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of temozolomide in patients with recurrent high-grade glioma has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasm
• High-grade Glioma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: University of California, San Francisco | Conditions: Recurrent Central Nervous System Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2013-10-29